Full-length IL-33 augments pulmonary fibrosis in an ST2- and Th2-independent, non-transcriptomic fashion-Reference-Cited by-同舟云学术

Full-length IL-33 augments pulmonary fibrosis in an ST2- and Th2-independent, non-transcriptomic fashion

Published:2023-01 Issue: Volume:383 Page:104657
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Luzina Irina G.,Lockatell Virginia,Courneya Jean-Paul,Mei Zhongcheng,Fishelevich Rita,Kopach Pavel,Pickering Edward M.,Kang Phillip H.,Krupnick Alexander S.,Todd Nevins W.,Vogel Stefanie N.,Atamas Sergei P.

Funder

U.S. Department of Veterans Affairs

National Institutes of Health

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Elsevier BV

Subject

Immunology

Reference68 articles.

1. Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family;Cayrol;Immunol. Rev.,2018

2. Emerging functions of IL-33 in homeostasis and immunity;Dwyer;Annu. Rev. Immunol.,2022

3. Interleukin-33 potentiates bleomycin-induced lung injury;Luzina;Am. J. Respir. Cell Mol. Biol.,2013

4. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice;Li;J. Allergy Clin. Immunol.,2014

5. The IL-33 receptor ST2 regulates pulmonary inflammation and fibrosis to bleomycin;Fanny;Front. Immunol.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases;Frontiers in Immunology;2024-09-05

2. Unveiling the multifaceted antitumor effects of interleukin 33;Frontiers in Immunology;2024-05-31

3. Unpacking the complexity of nuclear IL-33 (nIL-33): a crucial regulator of transcription and signal transduction;Journal of Cell Communication and Signaling;2023-10-25

4. Epithelial alarmins: a new target to treat chronic respiratory diseases;Expert Review of Respiratory Medicine;2023-09-02